Suppr超能文献

针刺治疗中风后吞咽困难:一项前瞻性、非随机、自身对照试验。

Acupuncture for Poststroke Dysphagia: A Pilot, Nonrandomized, Self-Controlled Trial.

作者信息

Chan Yu Tat, Zhang Hong Wei, Sun Wai Zhu, Hang Or Kevin Ka, Guo Yuan-Qi, Chen Min, Wu Guan-Yi, Xu Guang-Yao, Leung Connie, Tam Sylvia, Chun-Keung Mok Francis, Kwan Yiu Keung, Chow Eddie, Wo Mak Joshua Kam, Chun-Kwok Chu Angus, Lee Kathy, Law Thomas, Ming Wong Rita Wai, Lin Zhi-Xiu

机构信息

School of Chinese Medicine, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong.

Torrens University Australia, Melbourne, Victoria, Australia.

出版信息

Evid Based Complement Alternat Med. 2020 May 11;2020:4689296. doi: 10.1155/2020/4689296. eCollection 2020.

Abstract

OBJECTIVE

To evaluate the effectiveness and safety of acupuncture treatment for dysphagia as a complication of stroke. . This is a multicenter, pragmatic, nonrandomized, self-controlled clinical trial. A total of 39 patients were recruited from several Chinese medicine outpatient clinics and hospital-affiliated speech therapy outpatient clinics in Hong Kong. 26 patients completed all the 24 sessions of acupuncture treatment within two months, and only 12 of them were used as self-control. For the self-control group, the retrospective clinical data was taken from the electronic patient records with patient consent. The descriptive swallowing function data were converted into the quantitative Royal Brisbane Hospital Outcome Measure for Swallowing (RBHOMS) scores by two registered speech therapists through a validation process. And the data were validated by reaching consensus between the two speech therapists. All subjects underwent a baseline assessment before commencement of treatment, and outcome assessments were conducted upon the completion of treatment. The primary outcome measure is the RBHOMS score, which is a swallowing disability rating scale for monitoring difficulties in daily swallowing function. Secondary outcome measures include the Chinese version of the Swallow Quality-of-Life Questionnaire and adverse events. All the primary and secondary outcomes were assessed at baseline as well as at the end of acupuncture treatment (month 2).

RESULTS

A total of 39 participants aged 46 to 89 years were enrolled in the study, and the male-to-female ratio was 15 : 11. The mean baseline RBHOMS score of all 39 participants was 5.92 ± 2.23. The mean retrospective RBHOMS score of the 12 subjects who were used as self-control was 5.67 ± 1.72 before enrollment, while the mean RBHOMS score of the 26 participants who completed all the 24 sessions of treatment was 6.92 ± 2.07. There were statistically significant differences between the RBHOMS score at the completion of treatment and baseline (=0.006), and retrospective data (=0.042). Moreover, a significant difference was also found in terms of swallow quality-of-life score before and after acupuncture treatment ( < 0.01).

CONCLUSIONS

This pilot study provides preliminary evidence for the effectiveness of acupuncture for poststroke dysphagia. The findings from this trial can be used as a foundation for future full-scale randomized controlled clinical trials to assess the efficacy and safety of acupuncture for poststroke dysphagia. . The ethical approval of the clinical research study was granted by the Research Ethics Committee of both New Territories East and West Cluster of Hong Kong. Written informed consent was obtained from all participants, and the study was undertaken according to the ICH-GCP Guidelines. . This trial is registered with ChiCTR-TRC-12002621 and the registration date is 2012-10-26.

摘要

目的

评估针刺治疗中风并发症吞咽困难的有效性和安全性。这是一项多中心、务实、非随机、自身对照的临床试验。共从香港多家中医门诊和医院附属言语治疗门诊招募了39名患者。26名患者在两个月内完成了全部24次针刺治疗,其中仅12名用作自身对照。对于自身对照组,回顾性临床数据取自经患者同意的电子病历。两名注册言语治疗师通过验证过程将描述性吞咽功能数据转换为定量的皇家布里斯班医院吞咽结局测量量表(RBHOMS)评分。并且通过两名言语治疗师达成共识对数据进行了验证。所有受试者在治疗开始前接受基线评估,并在治疗完成后进行结局评估。主要结局指标是RBHOMS评分,这是一种吞咽残疾评定量表,用于监测日常吞咽功能困难。次要结局指标包括中文版吞咽生活质量问卷和不良事件。所有主要和次要结局均在基线以及针刺治疗结束时(第2个月)进行评估。

结果

共有39名年龄在46至89岁之间的参与者纳入研究,男女比例为15∶11。所有39名参与者的平均基线RBHOMS评分为5.92±2.23。用作自身对照的12名受试者在入组前的平均回顾性RBHOMS评分为5.67±1.72,而完成全部24次治疗的26名参与者的平均RBHOMS评分为6.92±2.07。治疗结束时的RBHOMS评分与基线(P=0.006)及回顾性数据(P=0.042)之间存在统计学显著差异。此外,针刺治疗前后吞咽生活质量评分也存在显著差异(P<0.01)。

结论

这项初步研究为针刺治疗中风后吞咽困难的有效性提供了初步证据。该试验的结果可作为未来全面随机对照临床试验的基础,以评估针刺治疗中风后吞咽困难的疗效和安全性。该临床研究已获得香港新界东及西联网研究伦理委员会的伦理批准。所有参与者均获得书面知情同意,且研究是按照国际人用药品注册技术协调会(ICH)-药品临床试验质量管理规范(GCP)指南进行的。本试验已在中国临床试验注册中心注册,注册号为ChiCTR-TRC-12002621,注册日期为2012年10月26日。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f550/7240803/ec5c2cd5cbab/ECAM2020-4689296.001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验